Artificial Intelligence (AI) platforms Could Enhance Jaguar Health’s development and anticipated commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs April 14, 2026
Blaize Announces Expected First Quarter 2026 Revenue and Newly Awarded Contract with NeoTensr Anticipated to Generate $50.0 Million in Revenue April 14, 2026